|
|
Volumn 141, Issue 1, 2011, Pages 396-399
|
|
A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: Between fear and hope
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
BETA INTERFERON;
BOCEPREVIR;
DANOPREVIR;
INTERFERON REGULATORY FACTOR 3;
MERICITABINE;
NONSTRUCTURAL PROTEIN 3;
NONSTRUCTURAL PROTEIN 4A;
PEGINTERFERON;
RIBAVIRIN;
RNA POLYMERASE;
TELAPREVIR;
VIRUS RNA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DRUG DOSE ESCALATION;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
FEAR;
GENE ACTIVATION;
GENOTYPE;
HEPATITIS C;
HEPATITIS C VIRUS;
HOPE;
HUMAN;
INNATE IMMUNITY;
INTERFERON FREE REGIMEN;
LIVER GRAFT;
MONOTHERAPY;
NONHUMAN;
NOTE;
PREVALENCE;
PRIORITY JOURNAL;
PROTEIN SECRETION;
SURVIVAL TIME;
SUSTAINED VIROLOGIC RESPONSE;
TREATMENT RESPONSE;
VIRUS REPLICATION;
VIRUS RESISTANCE;
|
|
EID: 79959977684
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2011.05.013 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
